{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "The City Weekly Desk", "lead_paragraph": "ROLAND CASH-MABRY coughs raspily into the translucent face mask that sends a medicinal mist into his airways, tightened by a severe asthma attack. The wheezing continues. After a few hours, he will leave Mount Sinai's pediatric emergency room and be assigned a hospital bed. The sufferer in the white T-shirt and black overalls is an old hand at this. He is checking in for his 14th hospital stay for asthma. But he still shakes his head in silent protest, perhaps at leaving his mother's side, for Roland is all of 2 years old.", "headline": {"main": "Breathless"}, "abstract": "Article on rise in number of childen with asthma in East Harlem, which, with highest rate of asthma-related hospital visits for children of any New York neighborhood, has become magnet for research and control projects; scientists and doctors from hospitals, city agencies and universities are looking at effects of pollution, triggers like cockroaches and mice, genetic role and how people take medications; photos (L)", "print_page": "1", "word_count": 2554, "_id": "4fd223958eb7c8105d7a9760", "snippet": "ROLAND CASH-MABRY coughs raspily into the translucent face mask that sends a medicinal mist into his airways, tightened by a severe asthma attack. The wheezing continues. After a few hours, he will leave Mount Sinai's pediatric emergency room and be...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/13/nyregion/breathless.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK CITY"}, {"name": "glocations", "value": "HARLEM (NYC)"}, {"name": "subject", "value": "COCKROACHES"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ASTHMA"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "HOSPITALS"}, {"name": "subject", "value": "AIR POLLUTION"}, {"name": "subject", "value": "MICE"}], "byline": {"person": [{"firstname": "Daniel", "middlename": "J.", "lastname": "WAKIN", "rank": 1, "role": "reported", "organization": ""}], "original": "By DANIEL J. WAKIN"}, "document_type": "article", "pub_date": "2001-05-13T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "Review", "blog": [], "news_desk": "Book Review Desk", "lead_paragraph": "NICKEL AND DIMED On (Not) Getting By in America. By Barbara Ehrenreich. 221 pp. New York: Metropolitan Books/ Henry Holt & Company. $23.", "headline": {"main": "Making Ends Meet"}, "abstract": "Dorothy Gallagher reviews Barbara Ehrenreich book, Nickel and Dimed: On (Not) Getting By in America; drawing (M)", "print_page": "10", "word_count": 1405, "_id": "4fd2152e8eb7c8105d78e82d", "snippet": "NICKEL AND DIMED   On (Not) Getting By in America.   By Barbara Ehrenreich.   221 pp. New York:   Metropolitan Books/   Henry Holt & Company. $23.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/13/books/making-ends-meet.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "NICKEL AND DIMED: ON (NOT) GETTING BY IN AMERICA (BOOK)"}, {"name": "persons", "value": "EHRENREICH, BARBARA"}, {"name": "subject", "value": "REVIEWS"}, {"name": "subject", "value": "BOOKS AND LITERATURE"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Dorothy", "lastname": "Gallagher"}], "original": "By Dorothy Gallagher"}, "document_type": "article", "pub_date": "2001-05-13T00:00:00Z", "section_name": "Arts; Books"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In a decision with far-reaching implications for health care in the United States, a federal district judge has ruled that poor people may not sue state officials to force them to provide benefits guaranteed under the federal Medicaid law. The decision, issued in March by Judge Robert H. Cleland of Detroit, has pleased state officials, but shocked some legal scholars and advocates for the poor.", "headline": {"main": "Ruling in Michigan Bars Suits Against State Over Medicaid"}, "abstract": null, "print_page": "18", "word_count": 667, "_id": "4fd2152e8eb7c8105d78e83c", "snippet": "In a decision with far-reaching implications for health care in the United States, a federal district judge has ruled that poor people may not sue state officials to force them to provide benefits guaranteed under the federal Medicaid law.    The...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/13/us/ruling-in-michigan-bars-suits-against-state-over-medicaid.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2001-05-13T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Letter", "blog": [], "news_desk": "New Jersey Weekly Desk", "lead_paragraph": "To The Editor: Jon Shure's Soapbox misses some important points that humanists, animal welfare and animal rights activists have emphasized for over a century: that those who callously exploit and hunt animals and are rewarded for it create a social climate that tolerates and justifies the exploitation of human beings.", "headline": {"main": "Fatter Horse Race Purses Are Good for the Economy"}, "abstract": "Norman Markowitz letter on Jon Shure's April 29 essay on New Jersey subsidies to racetrack purses holds animals should not be exploited and abused", "print_page": "13", "word_count": 227, "_id": "4fd249f08eb7c8105d7e7cb5", "snippet": "To The Editor:    Jon Shure's Soapbox misses some important points that humanists, animal welfare and animal rights activists have emphasized for over a century: that those who callously exploit and hunt animals and are rewarded for it create a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/13/nyregion/l-fatter-horse-race-purses-are-good-for-the-economy-272779.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MARKOWITZ, NROMAN"}, {"name": "persons", "value": "SHURE, JON"}, {"name": "glocations", "value": "NEW JERSEY"}, {"name": "subject", "value": "HORSE RACING"}, {"name": "subject", "value": "CRUELTY TO ANIMALS"}], "byline": null, "document_type": "article", "pub_date": "2001-05-13T00:00:00Z", "section_name": "New York and Region; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "IT would be unfair to call ''Nickel and Dimed: On (Not) Getting By in America,'' (Metropolitan Books, $23), by Barbara Ehrenreich, an extremely important business book. To many people, the term ''important business book'' inevitably conjures up images of wonkish tomes studded with equations that rely heavily on the Greek letter sigma. And that bears no resemblance to this captivating account of Ms. Ehrenreich's attempt to survive on the kind of low-paying jobs that politicians think will provide needy women with an alternative to welfare.", "headline": {"main": "A Humbling Tour of Entry-Level America", "kicker": "OFF THE SHELF"}, "abstract": "Diana B Henriques reviews Barbara Ehrenreich's book, Nickel and Dimed, journal of her first-hand experience as an unskilled laborer; photos (M)", "print_page": "7", "word_count": 861, "_id": "4fd225918eb7c8105d7acf98", "snippet": "IT would be unfair to call ''Nickel and Dimed: On (Not) Getting By in America,'' (Metropolitan Books, $23), by Barbara Ehrenreich, an extremely important business book.    To many people, the term ''important business book'' inevitably conjures up...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/13/business/off-the-shelf-a-humbling-tour-of-entry-level-america.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "NICKEL AND DIMED: ON (NOT) GETTING BY IN AMERICA (BOOK)"}, {"name": "persons", "value": "EHRENREICH, BARBARA"}, {"name": "subject", "value": "LABOR"}, {"name": "subject", "value": "BOOKS AND LITERATURE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By DIANA B. HENRIQUES"}, "document_type": "article", "pub_date": "2001-05-13T00:00:00Z", "section_name": "Business; Books"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "A proposal to make the three most popular and expensive allergy drugs available without a prescription won strong support yesterday from a government medical advisory panel. The panel voted overwhelmingly to advise the Food and Drug Administration that Claritin, Allegra and Zyrtec were just as safe as many nonprescription allergy medications that have long been sold in drugstores and supermarkets.", "headline": {"main": "Over-Counter Shift For Drugs Is Backed"}, "abstract": null, "print_page": "1", "word_count": 167, "_id": "4fd258778eb7c8105d804041", "snippet": "A proposal to make the three most popular and expensive allergy drugs available without a prescription won strong support yesterday from a government medical advisory panel.    The panel voted overwhelmingly to advise the Food and Drug Administration...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/12/business/over-counter-shift-for-drugs-is-backed.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2001-05-12T00:00:00Z", "section_name": "Front Page; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "A proposal to make the three most popular and expensive allergy drugs available without a prescription won strong support yesterday from a government medical advisory panel. The panel voted overwhelmingly to advise the Food and Drug Administration that Claritin, Allegra and Zyrtec were just as safe as many nonprescription allergy medications that have long been sold in drugstores and supermarkets.", "headline": {"main": "Panel Says 3 Allergy Drugs Should Be Sold Over the Counter"}, "abstract": null, "print_page": "1", "word_count": 904, "_id": "4fd249e98eb7c8105d7e7796", "snippet": "A proposal to make the three most popular and expensive allergy drugs available without a prescription won strong support yesterday from a government medical advisory panel.    The panel voted overwhelmingly to advise the Food and Drug Administration...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/12/business/panel-says-3-allergy-drugs-should-be-sold-over-the-counter.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2001-05-12T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Aetna Inc., the ailing health insurance giant, posted a first-quarter loss yesterday, citing an unexpected surge in medical costs, and said that its main business was in trouble and unlikely to recover before late next year. The company, the nation's largest health insurer, posted a net loss of $48.2 million, or 34 cents a share, in contrast to net income of $170 million, or $1.20 a share, in the quarter a year earlier.", "headline": {"main": "Aetna Reports a Loss As Medical Costs Surge"}, "abstract": "Aetna Inc posts net loss of $48.2 million in first quarter in contrast to net income of $170 million in year-earlier period; chief executive Dr John W Rowe comments (M)", "print_page": "11", "word_count": 861, "_id": "4fd22ff98eb7c8105d7be597", "snippet": "Aetna Inc., the ailing health insurance giant, posted a first-quarter loss yesterday, citing an unexpected surge in medical costs, and said that its main business was in trouble and unlikely to recover before late next year.    The company, the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/11/business/aetna-reports-a-loss-as-medical-costs-surge.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ROWE, JOHN W"}, {"name": "organizations", "value": "AETNA INC"}, {"name": "subject", "value": "COMPANY REPORTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2001-05-11T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "In an escalating battle between insurance companies and drug manufacturers over the rising cost of prescription medicines, one of the nation's largest health insurers will argue today at a federal hearing that Claritin, the top-selling prescription allergy drug, and two of its competitors should be sold over the counter. Wellpoint Health Networks, the large California health insurer, will argue before an advisory panel at the Food and Drug Administration that the drugs -- Claritin, Allegra and Zyrtec -- should be made more widely available. Wellpoint executives say the medications are safer than many of the other allergy drugs that are already sold over the counter.", "headline": {"main": "A Push to Sell Top Allergy Drugs Over the Counter"}, "abstract": "Wellpoint Health Networks, one of nation's largest health insurers, will tell advisory panel at Food and Drug Administration that three top-selling prescription allergy drugs should be sold over the counter; will claim Claritin, Allegra and Zyrtec are safer than many other allergy drugs already sold over counter; says drugs, which had combined sales in US of $4.7 billion last year, are putting growing financial burden on health care system; says it would save $45 million year if drugs are made available over counter and not covered by them; idea is opposed by Schering-Plough, Aventis and Pfizer, pharmaceutical companies that sell drugs and make hundreds of millions of dollars in revenue from them; companies say Wellpoint is trying to improve its bottom line by shifting responsibility for paying for drugs to patients from insurers; say proposal is not in best interest of patients; it is not clear that FDA has authority to force pharmaceutical companies to sell allergy drugs over counter; graph (M)", "print_page": "1", "word_count": 1276, "_id": "4fd22e5b8eb7c8105d7bc5d6", "snippet": "In an escalating battle between insurance companies and drug manufacturers over the rising cost of prescription medicines, one of the nation's largest health insurers will argue today at a federal hearing that Claritin, the top-selling prescription...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/11/business/a-push-to-sell-top-allergy-drugs-over-the-counter.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "organizations", "value": "WELLPOINT HEALTH NETWORKS INC"}, {"name": "organizations", "value": "SCHERING-PLOUGH CORP"}, {"name": "organizations", "value": "AVENTIS"}, {"name": "subject", "value": "ZYRTEC (DRUG)"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "CLARITIN (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ALLEGRA (DRUG)"}, {"name": "subject", "value": "ALLERGIES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2001-05-11T00:00:00Z", "section_name": "Front Page; Health; Business"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Increase in Medical Costs Contributes to Aetna Loss Aetna, the ailing health insurance giant, posted a first-quarter loss and said that its main business was in trouble and unlikely to recover before late next year. Aetna attributed the loss to an unforeseen 15 percent increase in medical costs, the highest reported by any big for-profit managed-care company. [C11.] Chicago Will Be Boeing's New Home After weeks of negotiations since it said it was leaving Seattle, Boeing chose Chicago over Dallas and Denver as its new home. [C3.] Changes by G.E.'s Next Chairman In his first major corporate and personnel move since becoming president and chairman-elect of General Electric, Jeffrey R. Immelt, left, named Gary L. Rogers, head of GE Plastics, as a corporate vice chairman and split the plastics business into two operations. The move points to growing confidence at G.E. that its deal for Honeywell International will ultimately be approved. [C3.] Appeal to F.D.A. on Allergy Drugs Wellpoint Health Networks will argue before an F.D.A. advisory panel today that Claritin, the top-selling prescription allergy drug, and two of its competitors should be made more widely available. [Page A1.] The F.D.A. approved Gleevec, a new kind of anti-cancer drug, after a swift, two-and-a-half month review of clinical data. [A1.] Microsoft Hires a Start-Up Ad Shop Microsoft is dismissing FCB Worldwide in San Francisco, which had served as the creative agency for the digital video recorder Ultimate TV, and hiring instead a San Francisco start-up shop. Stuart Elliott: Advertising. [C5.] W.W.F. and NBC Pull Plug on XFL The XFL expired, three weeks after the last game of its only season, a victim of dismal TV ratings, a subpar quality of play and inflated expectations. The demise of the football league is a highly visible failure for its parents, the World Wrestling Federation and NBC. [D1.] Markets Are Mixed as Rally Fizzles The latest attempt to sustain a rally on Wall Street fizzled. The Dow Jones industrial average closed up 43.46 points at 10,910.44. The Nasdaq composite index fell 27.77 points, to 2,128.86, while the Standard & Poor's 500-stock index slipped 0.36 point, to 1,255.18. [C6.] Retail Sales Climbed 3% in April Retailers' sales rose more than forecast in April, led by low-price chains like Wal-Mart. Sales at stores open at least a year rose 3 percent in April compared with March. Gap, the biggest clothing chain, showed improvement, although its sales still fell 2 percent. Analysts had expected a drop of as much as 10 percent. The April results lifted Gap's first-quarter profit above analysts' estimates. Its shares rose $3.61, to $32.41. [C5.] British Telecom Outlines Overhaul British Telecommunications outlined a widely anticipated corporate overhaul that would enable it to raise $8.4 billion and spin off its wireless division. [World Business, Section W.] Shift in Technology Helps I.B.M. Louis V. Gerstner Jr., chairman of I.B.M., said that the company was benefiting from a new golden age at its research laboratories and a shift in technology markets toward areas in which I.B.M. is especially strong. [C2.]", "headline": {"main": "BUSINESS DIGEST"}, "abstract": null, "print_page": "1", "word_count": 504, "_id": "4fd249f18eb7c8105d7e7d9d", "snippet": "Increase in Medical Costs Contributes to Aetna Loss  Aetna, the ailing health insurance giant, posted a first-quarter loss and said that its main business was in trouble and unlikely to recover before late next year.    Aetna attributed the loss to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/11/business/business-digest-268011.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2001-05-11T00:00:00Z", "section_name": "Business"}], "meta": {"hits": 31, "offset": 10, "time": 74}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}